IDXX
IDEXX Laboratories, Inc.
Diagnostics & Research · Healthcare · United States
566.93
close · 2026-08-13
value
12
cheaper than peers12
quality
83
stronger fundamentals83
ranked against
Diagnostics & Research
value
quality
28 peers
Value inputs
| measure | company | vs peers |
| forward P/E | 33.87× | 29 |
| price to sales | 10.15× | 28 |
| EV to EBITDA | 29.22× | 26 |
| price to book | 27.73× | 6 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 35.0% | 94 |
| return on equity | 74.2% | 94 |
| debt to equity | 68.0% | 40 |
| revenue growth | 9.7% | 38 |
4 of 4 measures available
Facts
| market cap | $45B |
| free cash flow | $909.4M |
| employees | 11,000 |
| first trade | 1991-06-21 |
| next earnings | 2026-08-04 |
| fundamentals updated | 2026-08-07 |